Home › Funds › Citadel Advisors › TEVA
Citadel Advisors position in TEVA
TEVA PHARMACEUTICAL INDS LTD · Health Care
Latest position (Q2 2026)4.24M sh
Reported value held$143.75M
Portfolio Weight0.02%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 9.21M | $89.69M | New |
| Q4 2021 | 6.93M | $55.49M | Reduce |
| Q1 2022 | 6.90M | $64.82M | Hold |
| Q2 2022 | 19.37M | $145.66M | Add |
| Q3 2022 | 8.63M | $69.65M | Reduce |
| Q4 2022 | 8.97M | $81.81M | Add |
| Q1 2023 | 12.43M | $110.04M | Add |
| Q2 2023 | 7.31M | $55.08M | Reduce |
| Q3 2023 | 5.77M | $58.88M | Reduce |
| Q4 2023 | 13.69M | $142.95M | Add |
| Q1 2024 | 8.32M | $117.39M | Reduce |
| Q2 2024 | 6.31M | $102.61M | Reduce |
| Q3 2024 | 6.30M | $113.58M | Hold |
| Q4 2024 | 10.63M | $234.18M | Add |
| Q1 2025 | 7.42M | $114.11M | Reduce |
| Q2 2025 | 6.14M | $102.93M | Reduce |
| Q3 2025 | 4.92M | $99.31M | Reduce |
| Q4 2025 | 8.09M | $252.51M | Add |
| Q1 2026 | 3.21M | $96.62M | Reduce |
| Q2 2026 | 4.24M | $143.75M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TEVA
- BlackRock Inc 63.89M sh · $2.16B · Q2 2026
- Norges Bank Investment Management 32.30M sh · $1.09B · Q2 2026
- Fidelity Management & Research (FMR) 30.26M sh · $1.03B · Q2 2026
- Capital World Investors 12.54M sh · $424.72M · Q2 2026
- Geode Capital Management 11.61M sh · $391.01M · Q2 2026
- Northern Trust Corp 7.96M sh · $269.58M · Q2 2026
- Wellington Management Group 7.67M sh · $259.90M · Q2 2026
- Morgan Stanley 6.97M sh · $236.10M · Q2 2026
- Goldman Sachs Group 6.13M sh · $207.66M · Q2 2026
- Janus Henderson Group 4.82M sh · $145.08M · Q1 2026
- Bank of America Corp 4.23M sh · $143.23M · Q2 2026